Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

Patients with hepatocellular carcinoma should be managed with a multidisciplinary
approach framed in a network where all the diagnostic techniques and therapeutic …

Importance Despite the acceptance of living-donor liver transplant (LDLT) as a lifesaving
procedure for end-stage liver disease, it remains underused in the United States …

Objectives: To compare long-term survival of living donor liver transplant (LDLT) at
experienced transplant centers with outcomes of deceased donor liver transplant and …

Recent modifications in organ allocation policies and increases in chronic liver diseases
may have resulted in important changes in living donor liver transplantation (LDLT) in the …

Hepatocellular carcinoma (HCC) represents an increasing fraction of liver transplant
indications; the role of living donor liver transplant (LDLT) remains unclear. In the Adult-to …

Living donor liver transplantation (LDLT) has emerged as an alternative to deceased donor
liver transplantation (DDLT) because of the increasing number of patients waiting for liver …

Background Early allograft dysfunction (EAD) after living donor liver transplantation (LDLT)
has often been attributed to inadequate graft size, and termed small-for-size syndrome. Early …

Living donor liver transplantation (LDLT), originally used in children with left lateral segment
grafts, has been expanded to adults who require larger grafts to support liver function. Most …

Candidates with hepatocellular carcinoma (HCC) within the Milan criteria (MC) receive
standardized Model for End‐Stage LIver Disease (MELD) exception points because of the …